Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126246322 | 12624632 | 2 | F | 20160730 | 20160909 | 20160805 | 20160915 | PER | PHEH2016US019309 | NOVARTIS | 66.75 | YR | F | Y | 58.00000 | KG | 20160915 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126246322 | 12624632 | 1 | PS | ESTRADIOL. | ESTRADIOL | 1 | Transdermal | UNK UNK, QW2 | 77993 | 19081 | PATCH | BIW | |||||||
| 126246322 | 12624632 | 2 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | Unknown | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 126246322 | 12624632 | 3 | C | BUPROPION XL | BUPROPION | 1 | Unknown | 150 MG, QD | 0 | 150 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126246322 | 12624632 | 1 | Product used for unknown indication |
| 126246322 | 12624632 | 2 | Headache |
| 126246322 | 12624632 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126246322 | 12624632 | Headache | |
| 126246322 | 12624632 | Inappropriate schedule of drug administration | |
| 126246322 | 12624632 | Product adhesion issue | |
| 126246322 | 12624632 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |